[Pharmacological effects of a new analgesic, 1-(m-methoxyphenyl)-2-dimethylaminomethyl cyclohexanol (1) hydrochloride (K-315). 2. Effects on electroencephalography and the afferent pathways].
D000438:Alcohols / Q000494:pharmacology*; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002421:Caudate Nucleus / Q000502:physiology; D003510:Cyclohexanes / Q000494:pharmacology*; D003511:Cyclohexanols / Q000494:pharmacology; D004558:Electric Stimulation; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D007031:Hypothalamus / Q000502:physiology; D007977:Levallorphan / Q000494:pharmacology; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008636:Mesencephalon / Q000502:physiology; D008744:Methylamines / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology; D011817:Rabbits; D012154:Reticular Formation / Q000502:physiology; D013153:Splanchnic Nerves / Q000502:physiology
D000438:Alcohols; D000700:Analgesics; D003510:Cyclohexanes; D003511:Cyclohexanols; D008744:Methylamines; D007977:Levallorphan; D009020:Morphine; D008614:Meperidine